<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        42-276-97
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FORTUM 1 g Powder for injection
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFTAZIDIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        37.20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GlaxoSmithKline Verona s.p.A." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GlaxoSmithKline Verona s.p.A.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Fortum contains a medicine called ceftazidime and belongs to a group of medicines called antibiotics. Antibiotics such as ceftazidime are used to treat infections in different parts of the body caused by bacteria.</p><p>Fortum is given by a doctor or nurse as an injection or infusion (drip) into a vein or an injection into a muscle. Fortum can be used in adults or in children (including new born babies).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Fortum:</strong></p><ul><li>if you are allergic to antibiotics such as <strong>cephalosporins or penicillins </strong>(<em>beta‑lactams</em>).</li></ul><p>&egrave;<strong>&nbsp; </strong>If you think this applies to you,<strong> don&rsquo;t use Fortum</strong> until you have checked with your doctor</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Take special care with Fortum</strong></p><p>Before you are given Fortum your doctor needs to know:</p><ul><li>if you have <strong>kidney disease</strong> your doctor may lower your dose of Fortum</li><li>if you need a <strong>low salt intake</strong></li></ul><p>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&egrave;&nbsp;&nbsp; Check with your doctor if you think this may apply to you.</p><p><strong>Look out for important symptoms</strong></p><p>Fortum can cause serious side effects, such as allergic reactions including serious skin rashes, nervous system disorders and severe diarrhoea (<em>pseudomembranous colitis</em>).&nbsp; You must look out for certain symptoms while you are receiving Fortum, to help reduce the risk of any problems. See &lsquo;<em>Look out for important symptoms&rsquo;</em> <strong>in Section 4</strong>.</p><p>While you are taking Fortum</p><p><strong>If you need a blood or urine test </strong></p><p>Fortum can affect the results of a blood test known as the Coombs test or urine tests for sugar for example Benedict&rsquo;s or Fehling&rsquo;s tests.<strong> </strong>If you need a blood or urine test<strong>:</strong></p><p>&egrave;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Te</strong><strong>ll the person taking the sample </strong>that you have been given Fortum.</p><p><strong>Giving other medicines, herbal or dietary supplements </strong></p><p><strong>Tell your doctor or pharmacist if you&#39;re taking any other medicines,</strong> if you&rsquo;ve taken any recently, or if you start taking new ones. This includes other medicines bought without a prescription. The following medication can affect how Fortum works, or make it more likely that you&rsquo;ll have side effects:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antibiotics such as chloramphenicol or aminoglycosides</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a type of water tablets known as loop diuretics (for example furosemide)</p><p>&egrave;&nbsp; <strong>Tell your doctor i</strong>f you are taking any of these.</p><p>Oral contraception</p><p>Fortum may reduce how well the contraceptive pill works. If you are taking the <strong>contraceptive pill </strong>while you are being treated with Fortum you also need to use a<strong> barrier method of contraception</strong> (such as condoms). Ask your doctor for advice.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you <strong>are pregnant,</strong> or <strong>think you could be</strong>, or if you are <strong>planning to become pregnant,</strong> <strong>your doctor</strong> will consider the benefit to you against the risk to your baby of taking Fortum while you&#39;re pregnant.</p><p>The ingredients in Fortum can pass into breast milk.&nbsp; <strong>If you are breast-feeding, you must check with your doctor</strong> before you take Fortum.</p><p><strong>Fortum contains sodium</strong></p><p>Each 1 g of Fortum contains 52 mg sodium; this should be considered if you need a low salt intake.</p><p>&egrave; <strong>Check with your doctor</strong> that Fortum is suitable for you.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;Effects on ability to drive and use machines</strong></p><p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Fortum will usually be given by a doctor or nurse either directly into a vein (<em>intravenously</em>) or into a muscle (<em>intramuscularly</em>) or it can be given as a <strong>drip </strong>(intravenous infusion).&nbsp; Your doctor will decide on the correct dose of Fortum depending on:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the severity and type of your infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your age</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; how well your kidneys are working.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have any questions about your dose of Fortum or how Fortum is given <strong>ask your doctor or nurse</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Look out for important symptoms</p><p>Severe allergic reactions</p><p>These occur very rarely (<strong>up to 1 in 10,000</strong> people). Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised and itchy rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of <em>the f</em>ace or mouth (<em>angioedema</em>), causing difficu<em>lty in bre</em>athing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure that can cause lightheadedness on standing up (<em>hypotension</em>).</p><p>&egrave;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms<strong> and stop treatment with Fortum. </strong></p><p>Serious skin reactions</p><p>Serious skin reactions are very rare in people taking Fortum (occur in up to <strong>1&nbsp;in&nbsp;10,000 </strong>people). Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) called <em>erythema multiforme</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (<em>Stevens-Johnson syndrome</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread rash with blisters and skin peeling on much of the body surface (<em>toxic epidermal necrolysis</em>).</p><p>&egrave;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms and<strong> stop treatment with Fortum.</strong></p><p>Nervous system disorders</p><p>These occur very rarely (<strong>up to 1 in 10,000</strong> people), particularly in people with kidney disease. Signs include: tremors, fits and sometimes coma.</p><p>&egrave;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms and<strong> stop treatment with Fortum.</strong></p><p>Severe diarrhoea (Pseudomembranous colitis)</p><p>While taking Fortum you may develop inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain and fever (<em>pseudomembranous colitis</em>). This effect can occur after stopping treatment with Fortum.</p><p>&egrave;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms<strong>.</strong></p><p>Other side effects that have occurred in people taking Fortum are:</p><p>Common side effects</p><p>These may affect <strong>up to 1 in 10 </strong>people:</p><ul><li>diarrhoea</li><li>red raised or itchy skin rash</li><li>swelling and redness along a vein when Fortum is injected into a vein</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain and swelling when Fortum is injected into a muscle</p><p>Common side effects that may show up in blood tests:</p><ul><li>an increase in a type of white blood cell (<em>eosinophilia</em>)</li><li>an increase in the number of blood platelets (cells that help blood to clot) (<em>thrombocytosis</em>)</li><li>an increase in enzymes produced by the liver</li><li>positive Coombs test (<em>see section 2</em>)</li></ul><p>Uncommon side effects</p><p>These may affect <strong>up to 1 in 100</strong> people:</p><ul><li>inflammation of the gut which can cause pain or diarrhoea which may contain blood (<em>colitis</em>)</li><li>thrush - fungal infections in the mouth or vagina</li><li>headache</li><li>dizziness</li><li>feeling sick (nausea) or being sick (vomiting)</li><li>stomach ache</li><li>fever</li><li>itching</li></ul><p>Uncommon side effects that may show up in blood tests:</p><ul><li>decrease in the number of white blood cells (<em>leucopenia or neutropenia</em>)</li><li>decrease in number of blood platelets (cells that help blood to clot) (<em>thrombocytopenia</em>)</li><li>an increase in the level of urea, urea nitrogen or serum creatinine in the blood</li></ul><p>Very rare side effects</p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><ul><li>yellowing of the whites of the eyes or skin (<em>jaundice</em>)</li><li>tingling or numbness of the hands or feet</li><li>unpleasant taste in the mouth</li></ul><p><strong>Very rare side effects that may show up in blood tests:</strong></p><ul><li>an increase in a certain type of white blood cell in the blood (<em>lymphocytosis</em>)</li><li>red blood cells destroyed too quickly (<em>haemolytic anaemia</em>)</li><li>severe decrease in number of white blood cells (<em>agranulocytosis</em>)</li></ul><p><strong>&nbsp;</strong></p><p><strong>If you get side effects</strong></p><p>&egrave; <strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Keep out of the reach and sight of children.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Fortum after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store Fortum dry powder below 30&deg;C.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Protect from light.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The recommended periods of storage after reconstitution are:</p><p>6 hours below 25&deg;C3 days in a refrigerator (4&deg;C)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Fortum contains</p><p>The active substance is ceftazidime.</p><p>Fortum powder for injection or infusion comes in different strengths either 1 g or 2 g ceftazidime.&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non active ingredients:</p><p>Sodium carbonate (anhydrous).</p><p>&nbsp;</p><p><em>&nbsp;</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                FORTUM Vials are available in carton packs each containing 1 or 5 vials.

Not all presentations are available in every country.

Not all packs are available in every country.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:&nbsp; </strong></p><p><strong>GlaxoSmithkline Manufacturing S.p.A*, Verona, Italy</strong></p><p><strong>The Marketing Authorization Holder and packed by:&nbsp; </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA&nbsp;</p><p>*member of the GlaxoSmithKline group of companies<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                GDS Version Number: GDS26
Date of issue: 02 April 2017
Fortum is a trademark owned by or licensed to the GSK group of companies 
© 2020 GSK GROUP OF COMPANIES, ALL RIGHTS RESERVED. 

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي فورتم على دواء يسمى سيفتازيديم وينتمي إلى مجموعة من الأدوية تسمى المضادات الحيوية. وتستخدم المضادات الحيوية مثل سيفتازيديم لعلاج العدوى في أجزاء مختلفة من الجسم الناجمة عن البكتيريا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم إعطاء فورتم من قبل الطبيب أو الممرضة كحقن أو كتسريب (بالتنقيط) في الوريد أو بالحقن في العضلات. ويمكن استخدام فورتم في البالغين أو الأطفال (بما في ذلك الأطفال حديثي الولادة).</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستعمل </strong><strong>فورتم</strong><strong>:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه المضادات الحيوية مثل السيفالوسبورين أو البنسلين (بيتا لاكتام).</p><p dir="RTL">&not;&nbsp;&nbsp; إذا كنت تعتقد أن هذا ينطبق عليك ، <strong>فلا تستخدم </strong><strong>فورتم </strong>حتى تستشير طبيبك</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إنتبه بعناية خاصة عند أستعمال </strong><strong>فورتم</strong></p><p dir="RTL">قبل أن تأخذ <strong>فورتم</strong> يجب أن يعرف طبيبك:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكلى، فقد يخفض طبيبك جرعتك من فورتم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تحتاج إلى طعام قليل الملح</p><p dir="RTL">&not;&nbsp;&nbsp; تحقق مع طبيبك إذا كنت تعتقد أن هذا قد ينطبق عليك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إنتبه للأعراض المهمة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">فورتم يمكن أن يسبب آثار جانبية خطيرة، مثل ردود الفعل التحسسية بما في ذلك طفح جلدي خطي، واضطرابات الجهاز العصبي، والإسهال الحاد (التهاب غشاء القولون الكاذب). يجب عليك الأنتباه لأعراض معينة أثناء تلقي فورتم، للمساعدة في تقليل مخاطر أي مشاكل. انظر &quot;ابحث عن الأعراض المهمة&quot; <strong>في القسم 4</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أثناء أخذك فورتم</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا كنت بحاجة إلى إجراء تحليل دم أو بول</strong></p><p dir="RTL">يمكن أن يؤثر فورتم على نتائج اختبار الدم المعروف باسم اختبار كومب، أو فحوصات البول للسكر على سبيل المثال فحوصات بيندكت أو فهلينج. إذا كنت بحاجة إلى فحص دم أو بول:</p><p dir="RTL">&not;&nbsp;&nbsp; <strong>أخبر الشخص الذي أخذ العينة</strong> أنك تأخذ فورتم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>عند أخذ أدوية أخرى، أو أعشاب أو المكملات الغذائية</strong></p><p dir="RTL"><strong>أخبر طبيبك أو الصيدلي إذا كنت تتناول أي أدوية أخرى</strong>، أو إذا كنت قد اخذت أي أدوية مؤخرًا، أو إذا بدأت في تناول أدوية جديدة. وهذا يشمل الأدوية الأخرى التي تم شراؤها دون وصفة طبية. الأدوية التالية يمكن أن تؤثر على طريقة عمل فورتم، أو تَزيد من احتمال تعرضك لآثار جانبية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية مثل الكلورامفينيكول أو الأمينوجليكوزيد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع من أقراص الماء المعروفة باسم مدرات البول الحلقي (على سبيل المثال فروسيميد)</p><p dir="RTL">&not;&nbsp;&nbsp; <strong>أخبر طبيبك إذا كنت تتناول أيًا من هذه الأدوية</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>وسائل منع الحمل عن طريق الفم</u></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يقلل فورتم من مدى فعالية حبوب منع الحمل. إذا كنتِ تتناولين <strong>حبوب منع الحمل</strong> أثناء علاجك باستخدام فورتم، فأنتِ بحاجة أيضًا إلى استخدام <strong>طريقة منع حمل آخرى</strong> (مثل الواقي الذكري). إسأل طبيبك للحصول على المشورة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنتِ <strong>حاملاً</strong>، أو تعتقدين أنكِ يمكن أن <strong>تكوني</strong> <strong>حاملاً</strong>، أو إذا كنتِ <strong>تخططين لكي تصبحي حاملاً </strong>، فسوف يفكر طبيبكِ في مدي المنفعة التي تحصلين عليها في مقابل الخطر الذي قد يتعرض له طفلك عند تناولك فورتم أثناء حملك.</p><p dir="RTL">يمكن أن تنتقل المكونات الموجودة في فورتم إلى حليب الأم. <strong>فإذا كنتِ ترضعين طفلكِ رضاعة طبيعية فيجب عليكِ استشارة طبيبكِ قبل تناولكِ فورتم</strong>.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>فورتم يحتوي على الصوديوم</strong></p><p dir="RTL">كل 1 جرام من فورتم يحتوي على 52ملجم. من الصوديوم. يجب أخذ ذلك بعين الاعتبار إذا كنت تحتاج إلى كمية قليلة من الملح.</p><p dir="RTL">&not;&nbsp;&nbsp; تحقق مع طبيبك ما إذا كان فورتم كان مناسب لك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التأثيرات على القدرة على القيادة واستخدام الآلات</strong></p><p dir="RTL">لم يتم الإبلاغ عن أي تأثيرات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عادة ما يتم إعطاء فورتم من قبل الطبيب أو الممرضة إما مباشرة في الوريد (عن طريق الحقن الوريدي) أو في العضلات (الحقن العضلي) أو يمكن إعطاءها <strong>بالتنقيط</strong> (التسريب في الوريد). سيقرر طبيبك الجرعة الصحيحة من فورتم اعتمادًا على:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شدة العدوى ونوعها</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عمرك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدى كفاءة عمل كليتيك.</p><p dir="RTL">إذا كانت لديك أي أسئلة حول جرعتك من فورتم أو طريقة إعطاء فورتم، <strong>اسأل طبيبك أو ممرضتك</strong>.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>إنتبه للأعراض المهمة</strong></p><p dir="RTL"><strong>تفاعلات الحساسية الشديدة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">وهذه نادرة الحدوث للغاية (<strong>ما يصل إلى 1 من كل 10000 شخص</strong>). تشمل علاماتها:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مرتفع مع حكة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في بعض الأحيان في الوجه أو الفم (وذمة وعائية)، مما يسبب صعوبة في التنفس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أنهيار عام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم الذي يمكن أن يسبب الدوار عند الوقوف (انخفاض ضغط الدم).</p><p dir="RTL">&not;&nbsp;&nbsp; <strong>اتصل بالطبيب على الفور</strong> إذا كنت تعاني من أي من هذه الأعراض <strong>وتوقف عن العلاج باستخدام </strong>فورتم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تفاعلات جلدية خطيرة</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">التفاعلات الجلدية الخطيرة نادرة جدًا عند الأشخاص الذين يتناولون فورتم (تحدث حتى <strong>1 من كل 10000 شخص</strong>). وتشمل العلامات:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي، قد يتورم، ويبدو مثل الأهداف الصغيرة (بقع داكنة مركزية تحيط بها منطقة شاحبة ، مع حلقة داكنة حول الحافة) تسمى حمامي متعددة الأشكال.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح على نطاق واسع مع ظهور بثور وتقشير في الجلد ، خاصة حول الفم والأنف والعينين والأعضاء التناسلية (متلازمة ستيفنز جونسون)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح على نطاق واسع مع ظهور بثور وتقشير الجلد على جزء كبير من سطح الجسم (تنخر البشرة السمي).</p><p dir="RTL">&not;&nbsp;&nbsp; اتصل بالطبيب على الفور إذا كنت تعاني من أي من هذه الأعراض وتوقف عن العلاج باستخدام فورتم.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اضطرابات الجهاز العصبي</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">هذه الإضطرابات نادرة الحدوث (بحد أقصى شخص <strong>واحد من كل 10000 شخص</strong>) ، خاصة في مرضى الكلى. علامات تشمل: إرتعاش ونوبات وأحيانا غيبوبة.</p><p dir="RTL">&not;&nbsp;&nbsp; <strong>اتصل بالطبيب على الفور</strong> إذا كنت تعاني من أي من هذه الأعراض <strong>وتوقف عن العلاج باستخدام فورتم</strong>.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإسهال الحاد (التهاب القولون الغشائي الكاذب)</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">أثناء تناولك فورتم، قد تصاب بالتهاب في القولون (الأمعاء الغليظة)، مما يسبب الإسهال، وعادة ما يصاحبه دم ومخاط، وآلام في المعدة وحمى (التهاب القولون الغشائي الكاذب). يمكن أن يحدث هذا التأثير بعد إيقاف العلاجبإستخدام فورتم.</p><p dir="RTL">&not;&nbsp;&nbsp; <strong>اتصل بالطبيب على الفور</strong> إذا ظهرت عليك أي من هذه الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية الأخرى التي حدثت في الأشخاص الذين يتناولون فورتم هي:</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الآثار الجانبية الشائعة</strong></p><p dir="RTL">قد تؤثر هذه الأثار على ما يصل إلى <strong>شخص من كل 10 أشخاص</strong>:</p><p dir="RTL">&bull;&nbsp;&nbsp; الإسهال</p><p dir="RTL">&bull;&nbsp;&nbsp; إلتهاب طفح جلدي مع إحمرار أو حكة</p><p dir="RTL">&bull;&nbsp;&nbsp; تورم واحمرار على طول الوريد عندما يتم حقن فورتم في الوريد</p><p dir="RTL">&bull;&nbsp;&nbsp; ألم وتورم عندما يتم حقن فورتم في العضلات</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الشائعة التي قد تظهر في فحوصات الدم:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; زيادة في عدد نوع من خلايا الدم البيضاء (الحمضات)</p><p dir="RTL">&bull;&nbsp;&nbsp; زيادة في عدد الصفائح الدموية (الخلايا التي تساعد على تجلط الدم) (كثرة الصفيحات)</p><p dir="RTL">&bull;&nbsp;&nbsp; زيادة في الانزيمات التي ينتجها الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp; اختبار كومبس الإيجابي (انظر القسم 2)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية غير شائعة</strong></p><p dir="RTL">قد يؤثر ذلك على ما يصل إلى <strong>شخص واحد من كل 100 شخص</strong>:</p><p dir="RTL">&bull;&nbsp;&nbsp; التهاب الأمعاء الذي يمكن أن يسبب ألم أو إسهال الذي قد يحتوي على الدم (إلتهاب القولون)</p><p dir="RTL">&bull;&nbsp;&nbsp; الالتهابات الفطرية في الفم أو المهبل</p><p dir="RTL">&bull;&nbsp;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp;&nbsp; الدوخة</p><p dir="RTL">&bull;&nbsp;&nbsp; الشعور بالغثيان أو الغثيان (القيء)</p><p dir="RTL">&bull;&nbsp;&nbsp; ألم المعدة</p><p dir="RTL">&bull;&nbsp;&nbsp; الحمى</p><p dir="RTL">&bull;&nbsp;&nbsp; الحكة</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الآثار الجانبية غير الشائعة التي قد تظهر في فحوصات الدم:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء (قلة الكريات البيض أو قلة العدلات)</p><p dir="RTL">&bull;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (الخلايا التي تساعد على تجلط الدم) (قلة الصفيحات)</p><p dir="RTL">&bull;&nbsp;&nbsp; زيادة مستوى اليوريا، أو النيتروجين في البول أو الكرياتينين في الدم</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية نادرة جدا</strong></p><p dir="RTL">قد يؤثر ذلك على ما <strong>يصل إلى 1 من كل 10000 شخص</strong>:</p><p dir="RTL">&bull;&nbsp;&nbsp; اصفرار بياض العينين أو الجلد (اليرقان)</p><p dir="RTL">&bull;&nbsp;&nbsp; وخز أو تخدر في اليدين أو القدمين</p><p dir="RTL">&bull;&nbsp;&nbsp; تغيير في الطعم في الفم</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الآثار الجانبية النادرة جدًا التي قد تظهر في اختبارات الدم:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; زيادة في نوع معين من خلايا الدم البيضاء في الدم (الخلايا اللمفاوية)</p><p dir="RTL">&bull;&nbsp;&nbsp; تدمير خلايا الدم الحمراء بسرعة كبيرة (فقر الدم الانحلالي)</p><p dir="RTL">&bull;&nbsp;&nbsp; انخفاض حاد في عدد خلايا الدم البيضاء (ندرة المحببات)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا حدث لك أي من هذه الآثار الجانبية</strong></p><p dir="RTL">&not;&nbsp;&nbsp; <strong>أخبر طبيبك أو الصيدلي</strong> إذا كانت أي من الآثار الجانبية المذكورة شديدة أو مزعجة ، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp; أحتفظ بالدواء بعيدا عن متناول ونظر الأطفال.</p><p dir="RTL">&bull;&nbsp;&nbsp; لا تستخدم فورتم بعد تاريخ انتهاء الصلاحية الموجود علي العبوة بعد كلمة &quot;Exp&quot;.</p><p dir="RTL">&bull;&nbsp;&nbsp; تخزنبودرة فورتم في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&bull;&nbsp;&nbsp; يخزن بعيداً عن مصدر الضوء.</p><p dir="RTL">&bull;&nbsp;&nbsp; المدة الموصى بها للتخزين بعد التحضير هي:</p><p dir="RTL">6 ساعات عندما يخزن تحت درجة حرارة 25 درجة مئوية</p><p dir="RTL">3 أيام عندما يخزن في الثلاجة (عند 4 درجات مئوية)</p><p dir="RTL">&bull;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عن طريق مياه الصرف أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. ومن شأن هذه التدابير أن تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي السيفتازيديم.</p><p dir="RTL">يأتي مسحوق فورتم للحقن أو التسريب في تركيزات مختلفة إما 1 جم أو 2 جم سيفتازيديم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp; المكونات الأخرى غير النشطة:</p><p dir="RTL">كربونات الصوديوم (اللامائية).</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر قارورة فورتم في عبوات كرتونية تحتوي كل منها على 1 أو 5 قوارير.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتوافر كل التراكيز في كل بلد.</p><p dir="RTL">لا تتوافر كل العبوات في كل بلد.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>صنع بواسطة:</strong></p><p dir="RTL">شركة جلاكسو سميث كلاين للتصنيع، إس. پي ، أيه*، فيرونا، ايطاليا</p><p dir="RTL"><strong>حامل ترخيص التسويق و</strong><strong>التعبئة بواسطة:</strong></p><p dir="RTL">شركة جلاكسو السعودية المحدودة * جدة ، المملكة العربية السعودية</p><p dir="RTL">*عضو مجموعة شركات جلاكسو سميث كلاين</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم النسخة: GDS26 
تاريخ الإصدار: 02 أبريل 2017

فورتم هي علامة تجارية مملوكة أو مرخصة لمجموعة شركات جلاكسو سميث كلاين
© 2020 مجموعة شركات جلاكسو سميث كلاين، جميع الحقوق محفوظة.

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FORTUM injection contains 1 g or 2 g of ceftazidime 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FORTUM injection contains 1 g or2 g of ceftazidime (as pentahydrate).  
Cetftazidime pentahydrate is formulated in a mixture with sodium carbonate. 
When constituted, this mixture provides a solution of ceftazidime sodium. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for injection/infusion 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of single or multiple infections caused by susceptible organisms.</p><p>May be used alone as first choice drug before the results of sensitivity tests are available.</p><p>May be used in combination with an aminoglycoside or most other beta-lactam antibiotics.</p><p>May be used with an antibiotic against anaerobes when the presence of <em>Bacteroides fragilis</em> is suspected.</p><p>Susceptibility to <em>FORTUM </em>will vary with geography and time and local susceptibility data should be consulted where available (<em>see Pharmacological properties, Pharmacodynamic effects</em>).</p><p>Indications include:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe infections e.g. - septicaemia, bacteraemia, peritonitis, meningitis</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infections in immunosuppressed patients</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infections in patients in intensive care, e.g. infected&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; burns</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; respiratory tract infections including lung infections in cystic fibrosis</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ear, nose and throat infections</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary tract infections</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin and soft tissue infections</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gastrointestinal, biliary and abdominal infections</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bone and joint infections</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infections associated with haemo- and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prophylaxis: prostatic surgery (transurethral resection).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage depends upon the severity, sensitivity, site and type of infection and upon the age and renal function of the patient.</p><p>Use <em>FORTUM</em> injection by intravenous (i.v.) or deep intramuscular (i.m.) injection. Recommended i.m. injection sites are the upper outer quadrant of the gluteus maximus or lateral part of the thigh.</p><p><em>FORTUM</em> solutions may be given directly into the vein or introduced into the tubing of a giving set if the patient is receiving parenteral fluids.</p><p>&bull; Adults</p><p>1 to 6 g/day in two or three divided doses by i.v. or i.m. injection.</p><p>Urinary tract and less severe infections:&nbsp; &ndash; 1 g every 12 hours.&nbsp;</p><p>Most infections:</p><p>&ndash;&nbsp; 1 g every 8 hours or 2 g every 12 hours.</p><p>Very severe infections particularly in immunocompromised patients including those with neutropenia:</p><p>&ndash;&nbsp; 2 g every eight or 12 hours, or 3 g every 12 hours.</p><p>Fibrocystic adults with pseudomonal lung infections:</p><p>&nbsp;- 100 to 150 mg/kg/day in three divided doses.</p><p>In adults with normal renal function 9 g/day has been used without ill effect.</p><p>When used as a prophylactic agent in prostatic surgery, 1 g should be given at the induction of anaesthesia. A second dose should be considered at the time of catheter removal.</p><p>&bull; Infants and children (greater than 2 months)</p><p>30 to 100 mg/kg/day in two or three divided doses.</p><p>Doses up to 150 mg/kg/day (maximum 6 g/day) in three divided doses may be given to infected immunocompromised or fibrocystic children or children with meningitis.</p><p>&bull; Neonates (0 to 2 months)</p><p>25 to 60 mg/kg/day in two divided doses.</p><p>In neonates, the serum half-life of ceftazidime can be three to four times that in adults.</p><p>&bull; Elderly</p><p>In view of the reduced clearance of ceftazidime in acutely ill elderly patients, the daily dosage should not normally exceed 3 g, especially in those over 80 years of age.</p><p>&bull; Renal Impairment</p><p>Ceftazidime<em> </em>is excreted unchanged by the kidneys. Therefore, in patients with impaired renal function, the dosage should be reduced.</p><p>An initial loading dose of 1 g should be given. Maintenance doses should be based on creatinine clearance as shown in Table 1:</p><p>Table 1: &nbsp;&nbsp; Recommended maintenance doses of <em>FORTUM</em> in renal insufficiency</p><table cellspacing="0" cellpadding="0" border="0" style="width:444.25pt"><tbody><tr><td style="border-color:black; height:.95in; vertical-align:top; width:111.0pt"><p><strong>Creatinine </strong></p><p><strong>Clearance </strong></p><p><strong>(ml / minute) </strong></p></td><td style="height:.95in; vertical-align:top; width:111.1pt"><p><strong>Approx. Serum creatinine </strong></p><p><strong>(micromoles / l) (mg / dl) </strong></p></td><td style="height:.95in; vertical-align:top; width:111.0pt"><p><strong>Recommended unit dose of <em>FORTUM</em> </strong></p><p><strong>(g) </strong></p></td><td style="height:.95in; vertical-align:top; width:111.1pt"><p><strong>Frequency of dosing </strong></p><p><strong>(hourly) </strong></p></td></tr><tr><td style="height:41.3pt; vertical-align:top; width:111.0pt"><p>&gt; 50</p></td><td style="height:41.3pt; vertical-align:top; width:111.1pt"><p>&lt; 150</p><p>(&lt;1.7)</p></td><td colspan="2" style="height:41.3pt; vertical-align:top; width:222.1pt"><p>Normal dosage</p></td></tr><tr><td style="height:40.3pt; vertical-align:top; width:111.0pt"><p>50 to 31</p></td><td style="height:40.3pt; vertical-align:top; width:111.1pt"><p>150 to 200 (1.7 to 2.3)</p></td><td style="height:40.3pt; vertical-align:top; width:111.0pt"><p>1.0</p></td><td style="height:40.3pt; vertical-align:top; width:111.1pt"><p>12</p></td></tr><tr><td style="height:40.7pt; vertical-align:top; width:111.0pt"><p>30 to 16</p></td><td style="height:40.7pt; vertical-align:top; width:111.1pt"><p>200 to 350 (2.3 to 4.0)</p></td><td style="height:40.7pt; vertical-align:top; width:111.0pt"><p>1.0</p></td><td style="height:40.7pt; vertical-align:top; width:111.1pt"><p>24</p></td></tr><tr><td style="height:40.3pt; vertical-align:top; width:111.0pt"><p>15 to 6</p></td><td style="height:40.3pt; vertical-align:top; width:111.1pt"><p>350 to 500 (4.0 to 5.6)</p></td><td style="height:40.3pt; vertical-align:top; width:111.0pt"><p>0.5</p></td><td style="height:40.3pt; vertical-align:top; width:111.1pt"><p>24</p></td></tr><tr><td style="height:42.5pt; vertical-align:top; width:111.0pt"><p>&lt; 5</p></td><td style="height:42.5pt; vertical-align:top; width:111.1pt"><p>&gt; 500 (&gt; 5.6)</p></td><td style="height:42.5pt; vertical-align:top; width:111.0pt"><p>0.5</p></td><td style="height:42.5pt; vertical-align:top; width:111.1pt"><p>48</p></td></tr></tbody></table><p>In patients with severe infections the unit dose should be increased by 50% or the dosing frequency increased. In such patients the ceftazidime serum levels should be monitored and trough levels should not exceed 40 mg/l.</p><p>In children the creatinine clearance should be adjusted for body surface area or lean body mass.</p><p>Haemodialysis</p><p>The serum half-life during haemodialysis ranges from 3 to 5 hours.</p><p>Following each haemodialysis period, the maintenance dose of <em>FORTUM</em> recommended in the above table should be repeated.</p><p>Peritoneal dialysis</p><p><em>FORTUM</em> may be used in peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD).</p><p>In addition to i.v. use, <em>FORTUM</em> can be incorporated into the dialysis fluid (usually 125 to 250 mg for 2 litres of dialysis solution).</p><p>For patients in renal failure on continuous arteriovenous haemodialysis or high flux haemofiltration in intensive therapy units; 1 g daily either as a single dose or in divided doses. For low-flux haemofiltration, follow the dosage recommended under impaired renal function.</p><p>For patients on venovenous haemofiltration and venovenous haemodialysis, follow the dosage recommendations in table 2 &amp; 3.</p><p>&nbsp;</p><p>Table 2: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Continuous venovenous haemofiltration dosage guidelines for FORTUM</p><p><strong>&nbsp;</strong>&nbsp;</p><table cellspacing="0" cellpadding="0" border="0" style="width:442.55pt"><tbody><tr><td rowspan="2" style="border-color:black; height:40.1pt; vertical-align:top; width:117.95pt"><p><strong>Residual renal function (creatinine clearance in ml/minute) </strong></p></td><td colspan="4" style="border-color:black; height:40.1pt; vertical-align:top; width:324.6pt"><p><strong>Maintenance dose (mg) for an ultrafiltration rate (ml/minute) of <sup>a</sup>: </strong></p></td></tr><tr><td style="height:27.6pt; vertical-align:top; width:81.0pt"><p><strong>5 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:81.0pt"><p><strong>16.7 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:76.45pt"><p><strong>33.3 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:86.15pt"><p><strong>50 </strong></p></td></tr><tr><td rowspan="2" style="border-color:black; height:40.4pt; vertical-align:top; width:117.95pt"><p><strong>Residual renal function (creatinine clearance in ml/minute) </strong></p></td><td colspan="4" style="height:40.4pt; vertical-align:top; width:324.6pt"><p><strong>Maintenance dose (mg) for an ultrafiltration rate (ml/minute) of <sup>a</sup>: </strong></p></td></tr><tr><td style="height:27.6pt; vertical-align:top; width:81.0pt"><p><strong>5 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:81.0pt"><p><strong>16.7 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:76.45pt"><p><strong>33.3 </strong></p></td><td style="height:27.6pt; vertical-align:top; width:86.15pt"><p><strong>50 </strong></p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:117.95pt"><p>0</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.3pt; vertical-align:top; width:76.45pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:86.15pt"><p>500</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:117.95pt"><p>5</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.3pt; vertical-align:top; width:76.45pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:86.15pt"><p>500</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:117.95pt"><p>10</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:76.45pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:86.15pt"><p>750</p></td></tr><tr><td style="border-color:black; height:26.4pt; vertical-align:top; width:117.95pt"><p>15</p></td><td style="height:26.4pt; vertical-align:top; width:81.0pt"><p>250</p></td><td style="height:26.4pt; vertical-align:top; width:81.0pt"><p>500</p></td><td style="height:26.4pt; vertical-align:top; width:76.45pt"><p>500</p></td><td style="height:26.4pt; vertical-align:top; width:86.15pt"><p>750</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:117.95pt"><p>20</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:81.0pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:76.45pt"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:86.15pt"><p>750</p></td></tr></tbody></table><p><sup>a- </sup>Maintenance dose to be administered every 12 hours.</p><p>Table 3:<em> FORTUM</em> dosage guidelines during continuous venovenous haemodialysis</p><table cellspacing="0" cellpadding="0" border="0" align="left" style="width:442.45pt"><tbody><tr><td rowspan="4" style="border-color:black; height:26.3pt; vertical-align:top; width:113.4pt"><p><strong>Residual renal function (creatinine clearance in ml/minute</strong>)</p></td><td colspan="6" style="border-color:black; height:26.3pt; vertical-align:top; width:329.05pt"><p><strong>Maintenance dose (mg) for a dialysate in flow rate of </strong><strong><sup>a</sup></strong><strong> : </strong></p></td></tr><tr><td colspan="3" style="height:26.3pt; vertical-align:top; width:2.25in"><p><strong>1.0 litre/hour </strong></p></td><td colspan="3" style="height:26.3pt; vertical-align:top; width:167.05pt"><p><strong>2.0 litres/hour </strong></p></td></tr><tr><td colspan="3" style="height:26.3pt; vertical-align:top; width:2.25in"><p>Ultrafiltration rate (litre/hour)</p></td><td colspan="3" style="height:26.3pt; vertical-align:top; width:167.05pt"><p>Ultrafiltration rate (litres/hour)</p></td></tr><tr><td style="height:26.4pt; vertical-align:top; width:.75in"><p>0.5</p></td><td style="border-color:black; height:26.4pt; vertical-align:top; width:.75in"><p>1.0</p></td><td style="border-color:black; height:26.4pt; vertical-align:top; width:.75in"><p>2.0</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>0.5</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>1.0</p></td><td style="height:26.4pt; vertical-align:top; width:59.05pt"><p>2.0</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:113.4pt"><p>0</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:59.05pt"><p>750</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:113.4pt"><p>5</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:59.05pt"><p>750</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:113.4pt"><p>10</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:59.05pt"><p>1000</p></td></tr><tr><td style="border-color:black; height:26.3pt; vertical-align:top; width:113.4pt"><p>15</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>500</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.3pt; vertical-align:top; width:59.05pt"><p>1000</p></td></tr><tr><td style="border-color:black; height:26.4pt; vertical-align:top; width:113.4pt"><p>20</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>1000</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.4pt; vertical-align:top; width:.75in"><p>750</p></td><td style="height:26.4pt; vertical-align:top; width:59.05pt"><p>1000</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><sup>a- </sup>Maintenance dose to be administered every 12 hours.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Patients with known hypersensitivity to cephalosporin antibiotics. 
Hypersensitivity to ceftazidime pentahydrate or to any of the excipients of the injection.  


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before beginning treatment establish whether the patient has a history of hypersensitivity reactions to ceftazidime, cephalosporins, penicillins or other drugs.</p><p>Special care is indicated in patients who have experienced an allergic reaction to penicillins or other beta-lactams.&nbsp;&nbsp;</p><p>If an allergic reaction to <em>FORTUM</em> occurs discontinue the drug.&nbsp; Serious hypersensitivity reactions may require epinephrine (adrenaline), hydrocortisone, antihistamine or other emergency measures.</p><p>Concurrent treatment with high doses of cephalosporins and nephrotoxic drugs such as aminoglycosides or potent diuretics (e.g. furosemide) may adversely affect renal function. Clinical experience has shown that this is not likely to be a problem with <em>FORTUM</em> at the recommended dose levels. There is no evidence that <em>FORTUM</em> adversely affects renal function at normal therapeutic doses.</p><p>Ceftazidime is eliminated via the kidneys, therefore the dosage should be reduced according to the degree of renal impairment. Neurological sequelae have occasionally been reported when the dose has not been reduced in patients with renal impairment (see Dosage and Administration &ndash; Renal Impairment and Adverse Reactions).</p><p>As with other broad spectrum antibiotics, prolonged use may result in the overgrowth of non-susceptible organisms (e.g. <em>Candida, enterococci</em>) which may require interruption of treatment or appropriate measures. Repeated evaluation of the patient&#39;s condition is essential.</p><p>Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p>As with other extended-spectrum cephalosporins and penicillins, some initially susceptible strains of <em>Enterobacter</em> spp. and <em>Serratia </em>spp. may develop resistance during <em>FORTUM</em> therapy. When clinically appropriate during therapy of such infections, periodic susceptibility testing should be considered.</p><p>Each 1 g of ceftazidime contains 52 mg of sodium. The sodium content must be taken into account in patients requiring sodium restriction</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concurrent use of high doses with nephrotoxic drugs may adversely affect renal function (<em>see Warnings and Precautions</em>).</p><p>Chloramphenicol is antagonistic <em>in vitro</em> with ceftazidime and other cephalosporins. The clinical relevance of this finding is unknown, but if concurrent administration of <em>FORTUM</em> with chloramphenicol is proposed, the possibility of antagonism should be considered.</p><p>In common with other antibiotics, ceftazidime may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>Ceftazidime<em> </em>does not interfere with enzyme-based tests for glycosuria but slight interference may occur with copper reduction methods (Benedict&#39;s, Fehling&#39;s, Clinitest).</p><p>Ceftazidime does not interfere in the alkaline picrate assay for creatinine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no experimental evidence of embryopathic or teratogenic effects, but as with all drugs, <em>FORTUM</em> should be administered with caution during the early months of pregnancy and early infancy.</p><p>Ceftazidime is excreted in human milk in small quantities and should be used with caution in breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Data from large clinical trials (internal and published) were used to determine the frequency of very common to uncommon undesirable effects.&nbsp; The frequencies assigned to all other undesirable effects were mainly determined using post-marketing data and refer to a reporting rate rather than a true frequency. The following convention has been used for the classification of frequency:</p><p>very common &ge;1/10,</p><p>common &ge;1/100 to &lt;1/10, uncommon &ge;1/1,000 to &lt;1/100,</p><p>rare &ge;1/10,000 to &lt;1/1,000, very rare &lt;1/10,000.</p><p>Infections and infestations</p><p>Uncommon: &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Candidiasis (including vaginitis and oral thrush). <strong>Blood and lymphatic system disorders </strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eosinophilia and thrombocytosis.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leucopenia, neutropenia, and thrombocytopenia.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lymphocytosis, haemolytic anaemia, and agranulocytosis.</p><p>Immune system disorders</p><p>Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anaphylaxis (including bronchospasm and/or hypotension). <strong>Nervous system disorders </strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache and dizziness.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paraesthesia.</p><p>There have been reports of neurological sequelae including tremor, myoclonia, convulsions, encephalopathy, and coma in patients with renal impairment in whom the dose of <em>FORTUM</em> has not been appropriately reduced.</p><p><strong>Vascular disorders </strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phlebitis or thrombophlebitis with i.v. administration.</p><p>Gastrointestinal disorders</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: &nbsp;&nbsp; &nbsp; Nausea, vomiting, abdominal pain, and colitis.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bad taste.</p><p>As with other cephalosporins, colitis may be associated with <em>Clostridium difficile</em> and may present as pseudomembranous colitis (<em>See Warnings and Precautions</em>).</p><p>Hepatobiliary disorders</p><p>Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient elevations in one or more of the hepatic enzymes, ALT (SGPT), AST (SOGT), LDH, GGT and alkaline phosphatase.&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaundice.</p><p>Skin and subcutaneous tissue disorders</p><table border="0" cellspacing="0" cellpadding="0" style="width:489px"><tbody><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Maculopapular or urticarial rash.</p></td></tr><tr><td><p>Uncommon:</p></td><td><p>&nbsp;</p></td><td><p>Pruritus.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>Angioedema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis.</p><p>&nbsp;</p></td></tr></tbody></table><p>General disorders and administration site conditions</p><table border="0" cellspacing="0" cellpadding="0" style="width:522px"><tbody><tr><td style="vertical-align:top"><p>Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td style="vertical-align:top"><p>Pain and/or inflammation after i.m. injection.</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon: &nbsp;&nbsp; &nbsp;</p><p><strong>Investigations </strong></p></td><td style="vertical-align:top"><p>Fever.</p></td></tr><tr><td style="vertical-align:top"><p>Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td style="vertical-align:top"><p>Positive Coombs test.</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:bottom"><p>As with some other cephalosporins, transient elevations of blood urea, blood urea nitrogen and/or serum creatinine have been observed.&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table><p>A positive Coombs test develops in about 5% of patients and may interfere with blood cross-matching.</p><p><strong>To report any side effect(s): </strong></p><p><strong><em>Kingdom of Saudi Arabia </em></strong></p><p><strong>-National Pharmacovigilance centre (NPC) </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext: 2317-2356-2353-2340</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting hotline: 19999</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc<strong> </strong></p><p><strong>&nbsp;</strong></p><p><strong>-GlaxoSmithKline - Head Office, Jeddah </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; 00966(012)6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: <u>s</u>audi.safety@gsk.com<u>&nbsp; </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms and Signs </strong></p><p>Overdosage can lead to neurological sequelae including encephalopathy, convulsions and coma.</p><p><strong>Treatment </strong></p><p>Serum levels of ceftazidime can be reduced by haemodialysis or peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mechanism of Action</p><p>Ceftazidime is bactericidal in action. It acts by inhibiting bacterial cell wall synthesis.</p><p>Pharmacodynamic Effects</p><p>The prevalence of acquired resistance is geographically and time dependent and for select species may be very high.&nbsp; Local information on resistance and prevalence of extended spectrum beta lactamase (ESBLs) producing organisms is desirable, particularly when treating severe infections.&nbsp;&nbsp;</p><table cellspacing="1" cellpadding="1" border="1" style="width:800px"><tbody><tr><td><p><strong><em>In vitro</em> susceptibility of micro-organisms to Ceftazidime </strong></p><p>&nbsp;</p><p>Where clinical efficacy of ceftazidime has been demonstrated in clinical trials this is indicated with an asterisk (*).</p></td></tr><tr><td><strong>Commonly Susceptible Species </strong></td></tr><tr><td><table cellspacing="0" cellpadding="0" border="0" style="width:6.45in"><tbody><tr><td style="border-color:black; height:83.4pt; vertical-align:top; width:6.45in"><table border="0" cellspacing="0" cellpadding="0" style="width:619px"><tbody><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p>Beta-hemolytic streptococci<em>* </em></p><p>Staphylococcus aureus (methicillin susceptible)*</p><p>Coagulase negative staphylococcus (methicillin susceptible)</p></td></tr></tbody></table></td></tr><tr><td style="border-color:black; height:207.5pt; vertical-align:top; width:6.45in"><p><u>Gram-negative aerobes:</u></p><p><em>Haemophilus influenzae</em>* including ampicillin-resistant strains</p><p><em>Haemophilus parainfluenzae </em></p><p><em>Neisseria gonorrhoeae </em>&nbsp;</p><p><em>Neisseria meningitidis</em>*</p><p><em>Pasteurella multocida Proteus </em>spp.*&nbsp; <em>Providencia</em> spp.</p><p><em>Salmonella</em> spp.&nbsp;</p><p><em>Shigella</em> spp.&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><table cellspacing="1" cellpadding="1" border="1" style="width:800px"><tbody><tr><td><strong>Species for which acquired resistance may be a problem </strong></td></tr><tr><td><p><u>Gram-negative aerobes:</u></p><p><em>Acinetobacter </em>spp.</p><p><em>Burkholderia cepacia</em>&nbsp;</p><p><em>Citrobacter </em>spp.*</p><p><em>Enterobacter </em>spp.*<em> </em></p><p><em>Escherichia coli</em>*&nbsp;</p><p><em>Klebsiella </em>spp. including <em>K. pneumoniae</em>*</p><p><em>Pseudomonas </em>spp. including <em>P. aeruginosa</em>*</p><p><em>Serratia</em> spp.*</p><p><em>Morganella morganii </em></p><p><em>Yersinia enterocolitica </em></p></td></tr><tr><td><p><u>Gram-positive aerobes:</u></p><p><em>Streptococcus pneumoniae</em>*</p><p>Viridans group streptococcus</p></td></tr><tr><td><table cellspacing="0" cellpadding="0" border="0" style="width:6.45in"><tbody><tr><td style="border-color:black; height:83.3pt; vertical-align:top; width:6.45in"><p><u>Gram-positive anaerobes:</u></p><p><em>Clostridium</em> spp. not including <em>C. difficile</em>&nbsp; <em>Peptostreptococcus </em>spp.</p><p><em>Propionibacterium </em>spp.</p></td></tr><tr><td style="border-color:black; height:41.9pt; vertical-align:top; width:6.45in"><p><u>Gram-negative anaerobes:</u></p><p><em>Fusobacterium</em> spp.</p></td></tr></tbody></table></td></tr><tr><td><strong>Inherently resistant organisms </strong></td></tr><tr><td><p><u>Gram-positive aerobes:</u></p><em>Enterococcus</em> spp. including<em> E. faecalis </em>and <em>E. faecium</em> <em>Listeria </em>spp.</td></tr><tr><td><p><u>Gram-negative aerobes:</u></p><p><em>Campylobacter </em>spp.</p></td></tr><tr><td><p><u>Gram-positive anaerobes:</u></p><em>Clostridium difficile</em>&nbsp;</td></tr><tr><td><p><u>Gram-negative anaerobes:</u></p><em>Bacteroides</em> spp. including <em>B. fragilis</em>&nbsp;</td></tr><tr><td><p><u>Others:</u></p><p><em>Chlamydia </em>spp.</p><p><em>Mycoplasma</em> spp.</p><p><em>Legionella</em> spp.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>After i.m. administration of 1 g, peak levels of&nbsp; 37 mg/1, are achieved rapidly.&nbsp; Five minutes after i.v. bolus injection of 1 g or 2 g, serum levels are, respectively, 87 and 170 mg/l. Distribution</p><p>Therapeutically effective concentrations are still present in the serum 8 to 12 hours after either i.v. or i.m. administration.&nbsp; Serum protein binding is about 10%.&nbsp; Concentrations in excess of the MIC for common pathogens can be achieved in tissues such as bone, heart, bile, sputum, aqueous humour, synovial, pleural and peritoneal fluids. Ceftazidime crosses the placenta readily, and is excreted in the breast milk. Penetration of the intact blood-brain barrier is poor resulting in low levels of ceftazidime in the cerebral spinal fluid (CSF) in the absence of inflammation. However, therapeutic levels of 4 to 20 mg/l or more are achieved in the CSF when the meninges are inflamed.</p><p>Metabolism</p><p>Ceftazidime is not metabolised in the body.</p><p>Elimination</p><p>Parenteral administration produces high and prolonged serum levels, which decrease with a half-life of about 2 hours. Ceftazidime is excreted unchanged, in active form into the urine by glomerular filtration; approximately 80 to 90% of the dose is recovered in the urine within 24 hours. Less than 1% is excreted via the bile, which limits the amount entering the bowel.</p><p>Special Patient Populations</p><p>Elimination of ceftazidime is decreased in patients with impaired renal function and the dose should be reduced (<em>see Dosage and Administration - Renal Impairment, Warnings and Precautions</em>).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No additional data of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium carbonate (anhydrous).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>FORTUM</em> is less stable in Sodium Bicarbonate Injection than in other i.v. fluids. It is not recommended as a diluent.&nbsp; <em>FORTUM</em> and aminoglycosides should not be mixed in the same giving set or syringe.&nbsp; Precipitation has been reported with vancomycin added to <em>FORTUM</em> in solution. Therefore, it would be prudent to flush giving sets and i.v. lines between administration of these two agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fortum dry powder should be stored below 30&deg;C, protected from light</p><p>The recommended periods of storage after reconstitution are:</p><p>6 hours below 25&deg;C</p><p>3 days in a refrigerator (4&deg;C)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>FORTUM Vials are available in Carton packs each containing 1 or 5 vials.</p><p>Fortum powder for solution for injection or infusion is packaged in clear Ph.Eur.Type III glass 60 ml or 77 ml vial with a bromobutyl rubber plug and a flip-off type aluminium overseal.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>FORTUM</em> for injection/infusion is compatible with most commonly used i.v. fluids.&nbsp; However, Sodium Bicarbonate Injection is not recommended as a diluent (<em>see Incompatibilities</em>).</p><p>All sizes of vials of <em>FORTUM</em> Injection are supplied under reduced pressure. As the product dissolves, carbon dioxide is released and a positive pressure develops.</p><p>Small bubbles of carbon dioxide in the constituted solution may be ignored.</p><p>Table 4: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Instructions for reconstitution&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:592px"><tbody><tr><td style="vertical-align:top"><p><strong>Vial Size </strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Amount of </strong></p><p><strong>Diluent to be added (ml) </strong></p></td><td style="vertical-align:top"><p><strong>Approximate </strong></p><p><strong>Concentration (mg/ml) </strong></p></td></tr><tr><td style="vertical-align:top"><p>1 g</p></td><td style="vertical-align:top"><p>Intramuscular</p><p>Intravenous bolus</p><p>Intravenous infusion</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 ml</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 ml</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 ml #</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20</p></td></tr><tr><td style="vertical-align:top"><p>2 g</p></td><td style="vertical-align:top"><p>Intravenous bolus</p><p>Intravenous infusion</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 ml</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 ml #</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 170</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40</p></td></tr></tbody></table><p># NOTE: Addition should be in two stages <em>(see text)</em></p><p>Solutions range from light yellow to amber depending on concentration, diluent and storage conditions used. Within the stated recommendations, product potency is not adversely affected by such colour variations.</p><p>Ceftazidime at concentrations between 1 mg/ml and 40 mg/ml is compatible with:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.9% Sodium Chloride Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M/6 Sodium Lactate Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compound Sodium Lactate Injection (Hartmann&#39;s Solution)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.225% Sodium Chloride and 5% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.45% Sodium Chloride and 5% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.9% Sodium Chloride and 5% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.18% Sodium Chloride and 4% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dextran 40 Injection 10% in 0.9% Sodium Chloride Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dextran 40 Injection 10% in 5% Dextrose Injection</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dextran 70 Injection 6% in 0.9% Sodium Chloride Injection&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; Dextran 70 Injection 6% in 5% Dextrose Injection.</p><p>Ceftazidime at concentrations between 0.05 mg/ml and 0.25 mg/ml is compatible with Intra-peritoneal Dialysis Fluid (Lactate).</p><p><em>FORTUM</em> may be constituted for i.m. use with 0.5% or 1% Lidocaine Hydrochloride Injection.</p><p>Both components retain satisfactory potency when ceftazidime at 4 mg/ml is mixed with:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydrocortisone (hydrocortisone sodium phosphate) 1 mg/ml in 0.9% Sodium Chloride Injection or 5% Dextrose Injection.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cefuroxime (cefuroxime sodium) 3 mg/ml in 0.9% Sodium Chloride Injection.</p><p>&nbsp;&nbsp;&nbsp;&nbsp; Cloxacillin (cloxacillin sodium) 4 mg/ml in 0.9% Sodium Chloride Injection.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heparin 10 IU/ml or 50 IU/ml in 0.9% Sodium Chloride Injection.</p><p>&nbsp;&nbsp;&nbsp; Potassium Chloride 10 mEq/l or 40 mEq/l in 0.9% Sodium Chloride Injection.</p><p>The contents of a 500 mg vial of <em>FORTUM</em> for injection, constituted with 1.5 ml Water for Injections, may be added to metronidazole injection (500 mg in 100 ml) and both retain their activity.</p><p>Preparation of solutions for i.m. or i.v. bolus injection</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Introduce the syringe needle through the vial closure and inject the recommended volume of diluent.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw the needle and shake the vial to give a clear solution.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invert the vial. With the syringe piston fully depressed insert the needle into the solution. Withdraw the total volume of solution into the syringe ensuring that the needle remains in the solution. Small bubbles of carbon dioxide may be disregarded.</p><p>Preparation of solutions for i.v. infusion from <em>FORTUM</em> injection (mini-bag or burette-type set)</p><p>Prepare using a total of 50 ml (for 1 g and 2 g vials) of compatible diluent, added in TWO stages as below.</p><p>1 g and 2 g vials for i.v. infusion:</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Introduce the syringe needle through the vial closure and inject 10 ml of diluent for the 1 g and 2 g vials.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw the needle and shake the vial to give a clear solution.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not insert a gas relief needle until the product has dissolved.&nbsp; Insert a gas relief needle through the vial closure to relieve the internal pressure.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer the reconstituted solution to final delivery vehicle (e.g. mini-bag or burette-type set) making up a total volume of at least 50 ml, and administer by intravenous infusion over 15 to 30 minutes.</p><p>NOTE: To preserve product sterility, it is important that the gas relief needle is not inserted through the vial closure before the product has dissolved.</p><p>&nbsp;</p><p>Not all presentations are available in every country.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:  
GlaxoSmithKline Manufacturing S.p.A.*,37135 Verona, Italy 

Packed by:  
Glaxo Saudi Arabia Ltd.* Jeddah, KSA  
Marketing Authorization Holder:  
Glaxo Saudi Arabia Ltd.* Jeddah, KSA  
*member of the GlaxoSmithKline group of companies 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number:  GDS26/IPI06 
Date of issue: 03 April 2018 
FORTUM is trademark owned by or licensed to GSK group of companies 
©2020 GSK group of companies, All Rights Reserved. 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>